BETA STEROLINI-Forte Steroli : Sterolini 100:1 Pentru uz Terapeutic 90 capsule

UN PUTERNIC STIMULANT CU SPECTRU LARG PENTRU SISTEMUL IMUNITAR

BETA-STEROLINI-Forte: UN PRODUS EXCUSIV de la ORGANIKA

IMUNOMODULATOR

RECOMANDARI:

Cancer, Sindrom Autoimun, Alergii, Astma, Artrita, Oboseala cronica, Fibromialgie, Hepatita C, Herpes, Imunodeficienta umana, Lupus, Stress, Afectiuni ale tiroidei, Afectiuni digestive, Diabet, Hipertrofie prostatica, Boli infectioase, Colesterol, Ateroscleroza

Produs recent, extrasele de Fitosteroli obtinute din plante combinate in PROPORTIA DE 100:1 reprezinta un supliment zilnic inegalabil pentru restaurarea, intarirea si balansarea sistemului imunitar si lupta impotriva oricarui fel de boala.

Cercetarile din SUA au aratat foarte clar ca o combinatie de 100:1 Steroli + Sterolini mareste considerabil activitatea celulelor ucigase (killer cells) care ataca, distrug si elimina din corp celulele canceroase atit in faze precoce cit si in faze avansate. Mareste de asemena numarul componentelor sistemului imunitar ca de exemplu Celulele-T, Interleukin-2 si Gama-interferon cu efecte de intarire puternica a sistemului imunitar.  S-au raportat numeroase cazuri de oprire a inaintarii bolii canceroase precum si de vindecare totala prin autodistrugera celulelor canceroase. Ajuta la eliminrea efectelor secundare ale chimoterapiei. Se recomanda pentru: toate tipurile de Cancer, Alergii, Astma, Artrita, Oboseala cronica, Fibromyalgie, Hepatita C, Herpes, Imunodeficienta umana, Lupus, Stress, Afectiuni ale tiroidei, Afectiuni digestive, Diabet, Adenom de prostata, Prostatita, Boli infectioase, Colesterol, Ateroscleroza etc. Printre altele previne si inbolnavirile cu virusuri gripale.

COMPOZITIE:

Beta-Steroli..............30 mg

Beta-Strerolini…….0,3 mg

ADMINISTRARE: 2-3 capsule pe zi (2 capsule pentru tratament normal, 3 capsule pentru un tratament mai intensiv. Se administreaza cu aproximativ 30 minute inainte de masa)

Se poate administra si preventiv 1capsula/zi (1-2 flacoane pe an)

Se asociaza bine sinergic cu Ciupercile Terapeutice si alte produse anti-cancerigene, anti hepato-virusi, anti-bacteriene, Esenta Organica - Imunitara  (Herbalist's Choice)

BIBLIOGRAFIE

1. The importance of Sitosterol and Sitosterolin in human and animal nutrition: Karl H.

Pegel; South African Journal of Science, V.93, pp. 263-268, June 1997.

2. Merck Index; 12 th Ed. 1996. S. Budavari (page 1467), Merck Research Laboratories.

3. Martindale; 32 nd Ed. 1999. K. Parfitt (page 1279), Pharmaceutical Press, U.S.A.

4.  Review. Plant Sterols: Biosynthesis, biological function and their importance to

human nutrition. V. Piironen, D.G. Lindsay, T.A. Miettinen, J. Toivo and A-M

Lampi; Journal of Science Food and Agriculture; 80: 939-966 (2000).

5.  Textbook of Pharmacology 2 nd Ed. 1980 W.C. Bowman and M.J. Rand (page 1.15), Blackwell Scientific Publications, London, Great Britain.

6. Textbook of Pharmacology 2 nd Ed. W.C. Bowman and M.J. Rand (page 28.36 and  39.13) Blackwell Scientific Publications, London, Great Britain.

7.  Textbook of Pharmacology 3 rd Print 1970. W.C. Bowman, M.J. Rand and G.B. West (page 362). Blackwell Scientific Publications, Colchester, Great Britain.

8. In reference to toxicology and pharmacology of the Sitosterin fraction of Hypoxis rooperi. H. Kündig. Notabene medicii, II, 358 - 363 (1981).

9. Pharmacokinetics and Bioavailability of ß-Sitosterol in the Beagle Dog. W.A.

Ritschel et. al. Drug Research 40 (1990) page 463-468.

10. The metabolism and pharmacokinetics of BSSG in man. Huntingdon Research

Centre (August 1982).

11. Studies of the pharmacokinetics of BSSG (adsorbed onto BSS) in human subjects

after oral doses Huntingdon Research Centre (September 1982).

12. A multicentric, placebo controlled, double-blind clinical trial of beta-sitosterol

(phytosterol) for the treatment of benign prostatic hyperplasia. Klippel K.F.; Hiltl

D.M. ad Schipp B. British Journal of Urology, V.80, pp. 427-432, 1997.

13.  Can dietary factors influence prostatic disease? M.S. Morton; A. Turkes; L. Denis

and K. Griffiths. BJU International (1999), 84, 549-554.

14.  ß-Sitosterol for the treatment of benign prostatic hyperplasia: A systematic review.

T.J. Wilt; R. MacDonald and A. Ishani. BJU International (1999), 83, 976-983.

15. Treatment of symptomatic benign prostatic hyperplasia with ß-Sitosterol: An 18-

month follow-up. R.R. Berges; A. Kassen and T. Senge. BJU International (2000),

85, 842-846.

16. Beta-Sitosterol and Beta-Sitosterol Glucoside stimulate human peripheral blood

lymphocyte proliferation: Implications for their use as an immuno-modulatory vitamin combination. P.J.D. Bouic; et al. Int. J. Immunopharmac. Vol. 18. pp 693-700, 1996.

17. Plant Sterol/Sterolin Supplement use in a cohort of South African HIV-infected

patients – effects on immunological and virological surrogate markers. P.J.D. Bouic,

et al. SAMJ: October 2001, Vol. 91, No.10

18. A prospective, controlled study to evaluate the effect of an essential sterol and sterolin

formulation as a putative modulator in FIV (feline immunodeficiency virus) infected

laboratory cats. J. Lamprecht, P. Bouic, M. Freestone and M. Austin. Presentation at

the 12 th World Aids Conference, Geneva, June 18 – July 3, 1998.

19. The effects of ß-Sitosterol (BSS) and ß-Sitosterol Glucoside (BSSG) mixture on

selected immune parameters of marathon runners: Inhibition of post marathon

immune suppression and inflammation. P.J.D. Bouic; et al. Int. J. Sports Med. 1999;

20: 258-262.

20. Plant sterols and sterolins: A review of their immune-modulating properties. P.J.D.

Bouic and J.H. Lamprecht. Altern. Med. Rev. 1999; 4: 170-177.

21. Antihyperglycemic and insulin-releasing effects of ß-Sitosterol 3-ß-D-Glucoside and

its Aglycone, ß-Sitosterol. M.D. Ivorra, et al. Archives of the International

Pharmacodyn, V. 296, pp. 224-231, 1988.

22. Flow Cytometric Analysis of the TH– TH shift in allergic individuals using Moducare (sterols/sterolins). L. Myers and P. Bouic.

23. Anti-inflammatory and anti-pyretic activities of ß-Sitosterol. M.B. Gupta, et al.

Planta Medica 39, pp. 157-163, 1980.

24. A pilot study of the clinical effects of a mixture of Beta-Sitosterol and Beta-Sitosterolin

glucoside in active rheumatoid arthritis (RA). I. Louw, et. Al. Abstract Nutrition

Week Congress, February 2002.

25. A randomised placebo-controlled trial of the efficacy of beta-sitosterol and its

glucoside as adjuvants in the treatment of pulmonary tuberculosis. P.R. Donald; et al.

Int. J. Tuberc. Lung. Dis. 1: 518-522, 1997.

26.  Mechanisms for Cholesterol homeostasis in rat jejuna mucosa: Effects of cholesterol,

sitosterol and lovastin. L.B. Nguyen, et al. Journal of Lipid Research 42, 2001 pg

195-200.

27.  A comparison of the survival benefit provided by putative immune modulators in the

FIV+ (Feline immunodeficiency virus infected) laboratory cat model. J. Lamprecht

et. al. Presentation at the 13 th World Aids Conference, Durban, 2000.

28. The anti-glucocorticoid effects of ß-sitosterol (BSS) and ß-sitosterol glucoside

(BSSG) mixture on human lymphocytes in vitro. P. Bouic, et. al. FASEB J (2000)

Volume 14 (4) Supp pages 30, Abstract LB 164.

29. PTH Immunological memory and activation status of HIV positive patients: non-

treated versus Moducare treated patient groups. G. Claassens, et. al. Poster Abstract.

Joint Congress: HIV Clinicians, Infectious Diseases, Infection Control, Travel

Medicine, Sexually Transmitted Diseases, Societies and Veterinary and Human

Public Health. 2- 6 December 2001, Stellenbosch.

30.  South African Medical Journal. Plant sterol/sterolin Supplement use in cohort of

South African HIV infected patients-Effects on Immunological and virological

surrogate markers. Oct 2001, Vol 91, N 10.

31.  Current Opinion Of Clinical Nutrition and Metabolic Care. The Role of Phytosterols

and phytosterolins in immune modulation: a review of the past ten years. November

2001, 4:471-475.

32.  Comparative changes in laboratory parameters of Specified Pathogen Free (SPF) and

non-Specified Pathogen Free (non-SPF) laboratory cats infected with Feline

Immunodeficiency Virus (FIV)M.W. Freestone 3,J.H. Lamprecht 1, M.E. Austin 2,

P.J.D. Bouic 4, A. Clark 3, W. Brittle 3 XIV International AIDS Conference

Barcelona July 7-12, 2002.

33.  Immunological memory and activation status of HIV positive patients: non-treated

versus Moducare™ treated patient groups P.J.D. Bouic, J.H. Lamprecht, G.

Claassens, A. Clark, W. Brittle, M. Freestone University of Stellenbosch, Dept.

Medical Microbiology, Faculty of Health Sciences, University of Stellenbosch, P.O.

Box 19063, Tygerberg 7505, South Africa. XIV International AIDS Conference

Barcelona July 7-12, 2002.

34.  Enhanced spontaneous apoptosis of CD4+ lymphocytes in Feline Immunodeficiency

Virus Infected (FIV+), Specified Pathogen Free (SPF) Cats, treated with the immune

modulator, beta-sitosterol/ Beta-sitosterol glucoside (MODUCARE ™) J.H.

Lamprecht1, P.J.D. Bouic 2, M. Freestone 3, M. Austin 4, A. Clark 3, W. Brittle

3.1 Department of Pharmacology, University of Stellenbosch, 61 Clarendon Street,

PAROW VALLEY, 7500, South Africa; 2 Department of Medical Microbiology,

University of Stellenbosch, Cape Town, South Africa; 3 Essential Sterolin Products,

Cape Town, South Africa; 4 Central Research Unit, University of Stellenbosch, Cape

Town, South Africa.

35.  Anti-cancer Agents Isolated from plants, Hartwell, 1976; 60:1031-106.

36.  Drug Discovery Today. Sterols and Sterolins: New drugs for our immune system.

P.J.D Bouic. Vol.7 14 July 2002.

37.  Aids Bulletin. Immunomodulation in HIV/AIDS: The Tygerberg/ Stellenbosch

University Experience. No 6 Vol 3 Sept 1997

38.  The Lancet. A randomised placebo controlled double blind clinical trial of

Beta-sitosterol in patients with benign prostatic hyperplasia. RR Burges, J Wiindier, HJ

Trampisch, TH Senge. Vol. 345, No. 8964, p 1529 – 1532, 17 June 1995